UAE is the first government to approve a vaccine against the Chinese coronavirus



[ad_1]

The need for clarity on the safety and efficacy of China’s vaccines has become more urgent after Sinopharm revealed that it had already vaccinated about a million people even before the end of clinical trials. The campaign has alarmed foreign scientists who say it exposes people to undue risk.

Chinese officials have repeatedly assured the public that the country’s coronavirus vaccines are safe, though they provide few details. Last month, Liu Jingzhen, president of Sinopharm said that none of the people who had received the company’s vaccines had experienced adverse reactions. He said “only a few had mild symptoms.”

In October, Zheng Zhongwei, a senior health official, said the government had set up a “tracking program” to track people who had been vaccinated, although he did not give details.

Sinovac Biotech, a Beijing-based private vaccine manufacturer, has already started exporting its vaccines to countries such as Indonesia and Brazil. Sinopharm, which has another vaccine in late testing, has said it is preparing to deliver 500 million doses worldwide, according to the state-run Science and Technology Daily newspaper.

It is unclear whether the Emirates will begin using the Chinese vaccine, which Sinopharm developed with the Beijing Institute of Biological Products, for mass inoculations. The government had already approved the vaccine for emergency use in September for front-line workers at risk of contracting Covid-19.

Some other countries where Sinopharm is conducting trials have Chinese vaccines to help protect their populations. Morocco says it is preparing to vaccinate 80 percent of its adults, initially relying on a Sinopharm vaccine, though it would wait for China to approve the vaccine, according to Médias24, a Moroccan news website.

Chinese vaccines are also attractive to developing countries because they could be easier to distribute. Sinopharm has said that its vaccines need to be refrigerated at temperatures of just 2 to 8 degrees Celsius (or 35 to 46 degrees Fahrenheit) and could remain stable for up to three years. In contrast, Pfizer and Moderna vaccines, which are made from genetic materials that fall apart when thawed, require industrial freezers, making transportation and storage difficult.

[ad_2]